indomethacin has been researched along with Anemia in 19 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dyspeptic symptoms, gastrointestinal bleeding, or the development of anaemia without dyspepsia in patients treated with indomethacin may be manifestations of peptic ulceration." | 7.64 | Gastric ulceration occurring during indomethacin therapy. ( Hart, FD; Huskisson, EC; Taylor, RT; Trapnell, DH; Whitehouse, GH, 1968) |
| "NO-indomethacin was dissolved in dimethyl formamide followed by i." | 5.42 | Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia. ( Cecchini, R; da Silva, RV; Malvezi, AD; Martins, MI; Martins-Pinge, MC; Panis, C; Pinge-Filho, P; Rizzo, LV; Tatakihara, VL; Yamada-Ogatta, SF; Yamauchi, LM; Zanluqui, NG, 2015) |
| " One hundred eight cancer patients who experienced progressive cachexia due to solid, mainly gastrointestinal tumors were randomized to receive twice daily a cyclo-oxygenase inhibitor (controls; indomethacin, 50 mg twice a day) or indomethacin and erythropoietin, provided on individual basis to prevent development of progressive anemia (study patients; indomethacin, 50 mg twice a day plus rhEPO; range, 12,000-30,000 units per week)." | 5.08 | Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. ( Bosaeus, I; Brevinge, H; Daneryd, P; Körner, U; Lindholm, E; Lundholm, K; Pettersson, C; Sandström, R; Svanberg, E, 1998) |
| "Dyspeptic symptoms, gastrointestinal bleeding, or the development of anaemia without dyspepsia in patients treated with indomethacin may be manifestations of peptic ulceration." | 3.64 | Gastric ulceration occurring during indomethacin therapy. ( Hart, FD; Huskisson, EC; Taylor, RT; Trapnell, DH; Whitehouse, GH, 1968) |
| "NO-indomethacin was dissolved in dimethyl formamide followed by i." | 1.42 | Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia. ( Cecchini, R; da Silva, RV; Malvezi, AD; Martins, MI; Martins-Pinge, MC; Panis, C; Pinge-Filho, P; Rizzo, LV; Tatakihara, VL; Yamada-Ogatta, SF; Yamauchi, LM; Zanluqui, NG, 2015) |
| " The dose-response to vasoconstrictors and vasodilators was assessed in small resistance coronary arteries." | 1.35 | Effect of fetal anaemia on myocardial ischaemia-reperfusion injury and coronary vasoreactivity in adult sheep. ( Davis, LE; Giraud, GD; He, GW; Hohimer, AR; Underwood, MJ; Van Winkle, DM; Yang, Q, 2008) |
| "Another therapy involves the treatment for premature labor, which is the most common cause of pregnancy loss in dialysis patients." | 1.29 | Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. ( Ambrose, S; Hou, S; Hussey, M; Orlowski, J; Pahl, M; Wong, D, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Marini, D | 1 |
| Xu, J | 1 |
| Sun, L | 1 |
| Jaeggi, E | 1 |
| Seed, M | 1 |
| Gephart, SM | 1 |
| Underwood, MA | 1 |
| Rosito, S | 1 |
| Kim, JH | 1 |
| Caplan, MS | 1 |
| Yamamoto, A | 1 |
| Itoh, T | 1 |
| Nasu, R | 1 |
| Nishida, R | 1 |
| Tatakihara, VL | 1 |
| Malvezi, AD | 1 |
| Panis, C | 1 |
| Cecchini, R | 1 |
| Zanluqui, NG | 1 |
| Yamauchi, LM | 1 |
| Martins, MI | 1 |
| da Silva, RV | 1 |
| Yamada-Ogatta, SF | 1 |
| Rizzo, LV | 1 |
| Martins-Pinge, MC | 1 |
| Pinge-Filho, P | 1 |
| Yang, Q | 1 |
| Hohimer, AR | 1 |
| Giraud, GD | 1 |
| Van Winkle, DM | 1 |
| Underwood, MJ | 1 |
| He, GW | 1 |
| Davis, LE | 1 |
| Kelsey, WM | 1 |
| Scharyj, M | 1 |
| Sawamura, M | 1 |
| Yamaguchi, S | 1 |
| Murakami, H | 1 |
| Kitahara, T | 1 |
| Itoh, K | 1 |
| Maehara, T | 1 |
| Kawada, E | 1 |
| Matsushima, T | 1 |
| Tamura, J | 1 |
| Naruse, T | 1 |
| Hou, S | 1 |
| Orlowski, J | 1 |
| Pahl, M | 1 |
| Ambrose, S | 1 |
| Hussey, M | 1 |
| Wong, D | 1 |
| Schiffl, H | 1 |
| Lang, SM | 1 |
| Daneryd, P | 2 |
| Svanberg, E | 1 |
| Körner, U | 1 |
| Lindholm, E | 1 |
| Sandström, R | 1 |
| Brevinge, H | 1 |
| Pettersson, C | 1 |
| Bosaeus, I | 1 |
| Lundholm, K | 1 |
| Taniguchi, S | 1 |
| Shibuya, T | 1 |
| Harada, M | 1 |
| Niho, Y | 1 |
| Flynn, JT | 1 |
| Datta, MC | 1 |
| Spears, HJ | 1 |
| Dowla, HA | 1 |
| Smyth, CJ | 1 |
| Gaetani, M | 1 |
| Debeus, R | 1 |
| Vidi, A | 1 |
| Coppi, G | 1 |
| Julou, L | 1 |
| Ducrot, R | 1 |
| Fournel, J | 1 |
| Ganter, P | 1 |
| Populaire, P | 1 |
| Durel, J | 1 |
| Myon, J | 1 |
| Pascal, S | 1 |
| Pasquet, J | 1 |
| Jacobsen, CD | 1 |
| Taylor, RT | 1 |
| Huskisson, EC | 1 |
| Whitehouse, GH | 1 |
| Hart, FD | 1 |
| Trapnell, DH | 1 |
4 reviews available for indomethacin and Anemia
| Article | Year |
|---|---|
Current and future role of fetal cardiovascular MRI in the setting of fetal cardiac interventions.
Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Atrial Septum; Blood Transfusion, Intrauterine; Duc | 2020 |
Grading the evidence to identify strategies to modify risk for necrotizing enterocolitis.
Topics: Adrenal Cortex Hormones; Anemia; Anti-Bacterial Agents; Ductus Arteriosus, Patent; Enterocolitis, Ne | 2020 |
Retrolental fibroplasia: update.
Topics: Anemia; Blood Vessels; Carbon Dioxide; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Mal | 1986 |
Optimum therapeutic program in seropositive nodular rheumatoid arthritis.
Topics: Adaptation, Psychological; Analgesics; Anemia; Anti-Inflammatory Agents; Antimalarials; Arthritis, R | 1968 |
2 trials available for indomethacin and Anemia
| Article | Year |
|---|---|
Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.
Topics: Aged; Anemia; Anti-Inflammatory Agents, Non-Steroidal; Cachexia; Cyclooxygenase Inhibitors; Energy M | 1998 |
Epoetin alfa for protection of metabolic and exercise capacity in cancer patients.
Topics: Aged; Anemia; Anti-Inflammatory Agents, Non-Steroidal; Cachexia; Cyclooxygenase Inhibitors; Energy M | 2002 |
13 other studies available for indomethacin and Anemia
| Article | Year |
|---|---|
Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats.
Topics: Alginates; Anemia; Animals; Anti-Ulcer Agents; Atrophy; Bacterial Translocation; Biomarkers; Capilla | 2014 |
Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia.
Topics: Anemia; Animals; Cells, Cultured; Disease Susceptibility; Erythrocytes; Female; Indomethacin; Macrop | 2015 |
Effect of fetal anaemia on myocardial ischaemia-reperfusion injury and coronary vasoreactivity in adult sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anemia; Animals; Cardiovascular | 2008 |
Fatal hepatitis probably due to indomethacin.
Topics: Anemia; Chemical and Drug Induced Liver Injury; Child; Humans; Indomethacin; Male | 1967 |
Cyclic haemopoiesis at 7- or 8-day intervals.
Topics: Adult; Anemia; C-Reactive Protein; Erythropoietin; Female; Fever; Granulocyte Colony-Stimulating Fac | 1994 |
Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor.
Topics: Abnormalities, Drug-Induced; Adult; Anemia; Erythropoietin; Female; Hematocrit; Humans; Hypertension | 1993 |
Hypertension induced by recombinant human erythropoietin (rHU-EPO) can be prevented by indomethacin. Pathogenetic role of cytosolic calcium.
Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Calcium; Cytosol; Erythropoietin; | 1997 |
Prostaglandin-mediated suppression of in vitro growth of erythroid progenitor cells.
Topics: Anemia; Cell Division; Erythroid Precursor Cells; Erythropoietin; Humans; In Vitro Techniques; Indom | 1989 |
Relationship between plasma PGE2 level and changes in hemoglobin proportions during bleeding-induced anemia in adult rats.
Topics: Anemia; Animals; Aspirin; Dinoprostone; Erythropoiesis; Gene Expression Regulation; Hemoglobins; Hem | 1987 |
Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in
Topics: Administration, Oral; Aminohippuric Acids; Anemia; Animals; Anti-Inflammatory Agents; Benzyl Compoun | 1972 |
[Toxicologic study of methiazinic acid (16091 R.P)].
Topics: Abnormalities, Drug-Induced; Acetates; Anemia; Animals; Dogs; Drug Tolerance; Female; Gastric Mucosa | 1969 |
[Drug-induced anemias].
Topics: Adrenal Cortex Hormones; Anemia; Barbiturates; Bone Marrow; Chloramphenicol; Chlorpromazine; Dihydro | 1970 |
Gastric ulceration occurring during indomethacin therapy.
Topics: Adult; Aged; Anemia; Dyspepsia; Female; Humans; Indomethacin; Male; Middle Aged; Pylorus; Radiograph | 1968 |